Structural Heart Disease Moderators: Horst Sievert, MD, FSCAI and Jonathan M. Tobis, MD, FSCAI
- 10:30 AM Atrial Appendage Occlusion: Current Status Mark Reisman, MD, FSCAI
- 10:50 AM PFO-ASD Closure: Who to Treat and Why? Jonathan M. Tobis, MD, FSCAI
- 11:10 AM PFO-ASD Closure: How to Treat and With What?
Horst Sievert, MD, FSCAI
- 11:30 AM Post MI VSD Ziyad M. Hijazi, MD, FSCAI
Interventional Pharmacology Moderators: Paul A. Gurbel, MD, FSCAI and Magnus Ohman, MD, FSCAI
- 1:00 PM Platelet ‘Variable Responsiveness’: Frequency and Implications of Antiplatelet Therapy Resistance Paul A. Gurbel, MD, FSCAI
- 1:20 PM Oral Antiplatelet Therapy After DES: How Much and How Long?
Peter B. Berger, MD, FSCAI
- 1:40 PM GPIIbIIIa Inhibition in PCI and NSTE ACS:
Standard of Care or Still Needed? John J. Young, MD, FSCAI
- 2:00 PM Antithrombin Therapy in PCI: Recommendations for Clinical Practice
Magnus Ohman, MD, FSCAI
Debates Moderators: Theodore A. Bass, MD, FSCAI and Frederick Feit, MD
- 3:30 PM The 90 Minute Goal for Primary PCI in AMI is Nonsense
Timothy D. Henry, MD, FSCAI
- 3:40 PM The 90 Minute Goal for Primary PCI is Critical Eric R. Bates, MD
- 3:50 PM Rebuttal and Questions
Lovenox vs Heparin+ IIB/IIIA vs Bivalirudin
- 4:00 PM Lovenox James J. Ferguson, III, MD
- 4:10 PM Heparin + IIB/IIIA James E. Tcheng, MD, FSCAI
- 4:20 PM Bivalirudin Frederick Feit, MD
- 4:30 PM Rebuttal and Questions
- 4:40 PM Acute MI with Multivessel Disease: Fix Them All David A. Cox, MD, FSCAI
- 4:50 PM Acute MI with Multivessel Disease: Fix The Culprit and
Worry about the Rest Later
- 5:00 PM Rebuttal and Questions
- 5:10 PM LM PCI: Surgery is the Gold Standard Michael Mack, MD
- 5:20 PM LM PCI: The Time has Come for PCI Roxana Mehran, MD, FSCAI
